Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Hookipa Biotech initiates first-in-human study of HB-101 vaccine for CMV

June 29, 2016

Spero Therapeutics presents new MvfR inhibitor for P. aeruginosa infections

June 28, 2016

European Commission approves Zavicefta for serious bacterial infections

June 28, 2016

Carbavance meets primary endpoints in phase III TANGO 1 study in patients with cUTI

June 28, 2016

Shanghai Sun-Sail Pharmaceutical Science & Technology describes antituberculosis compounds

June 28, 2016

FDA places clinical hold on Regulus' IND for RG-101 for chronic HCV infection

June 28, 2016

Regulatory dossier for Sanofi Pasteur's VaxigripTetra approved in Europe

June 27, 2016

Genticel reports 18-month data from phase II trial of HPV immunotherapeutic candidate

June 27, 2016

VBI Vaccines cleared to begin phase I study of CMV vaccine candidate in Canada

June 27, 2016

New Pharma Licence Holdings develops antibacterial agents

June 27, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...